First Trust NYSE Arca Biotechnology Index Fund (FBT) Stock Overview
Explore First Trust NYSE Arca Biotechnology Index Fund’s financial performance, market position, analyst ratings, and future outlook.
First Trust NYSE Arca Biotechnology Index Fund (FBT)
Key Financials
Key Financials
Market Cap
1.7B
P/E Ratio
N/A
EPS (TTM)
$9.15
ROE
0.00%
FBT Stock Analysis & Investment Overview (AMEX)
Our AI-powered analysis of First Trust NYSE Arca Biotechnology Index Fund (AMEX: FBT) gives investors deep insight into how the stock performs on the AMEX exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, First Trust NYSE Arca Biotechnology Index Fund's AMEX-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of FBT on the AMEX shows an RSI of 55.06, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $215.79 for the AMEX listing.
Key metrics behind First Trust NYSE Arca Biotechnology Index Fund's AMEX-traded stock include a P/E ratio of N/A and a market capitalization of 1.7B. Combined with our AI analysis, these give both institutional and retail investors a clear view of FBT on the AMEX.